RxDoctor Payments DataLook up a doctor →

David Bryant, MD

Radiation Oncology · Wichita, KSNPI 1124000435

Payments from drug & device makers

$15,017in general payments, 2019–2025

Across 530 payments — averaging $28.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Accuray Incorporated$2K
  • AstraZeneca$1K
  • AbbVie$859
  • Johnson & Johnson$644
  • Eisai Inc.$642
  • Regeneron Healthcare Solutions, Inc.$555
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Accuray Incorporated9$1,596
AstraZeneca(2 entities)39$1,321
AbbVie11$859
Johnson & Johnson(2 entities)20$644
Eisai Inc.23$642
Regeneron Healthcare Solutions, Inc.16$555
Amgen30$536
Novocure Inc.6$475
Novartis26$465
Tersera Therapeutics LLC20$462
Seagen Inc.12$386
Merck21$367
Genentech USA, Inc.7$337
Puma Biotechnology, Inc.8$323
Sanofi17$293
GSK10$271
AVEO Pharmaceuticals, Inc.13$253
Stemline Therapeutics Inc.8$247
Bristol Myers Squibb9$242
Takeda Pharmaceuticals U.S.A., Inc.14$235
Ipsen Biopharmaceuticals, Inc14$234
Bayer15$234
Astellas Pharma US Inc2$221
Dendreon Pharmaceuticals LLC7$190
Daiichi Sankyo Inc.4$186
Pharmacyclics LLC, An Abbvie Company12$173
Verastem, Inc.2$137
Blueprint Medicines Corporation8$137
Beigene USA, Inc.1$125
Epizyme, Inc.1$125
Taiho Oncology, Inc.7$124
Incyte Corporation8$120
Intuitive Surgical1$118
Sun Pharmaceutical Industries Inc.7$117
Sumitomo Pharma America, Inc.6$112
Sanofi-aventis U.S. LLC2$103
Pharmaessentia USA Corporation6$102
Boehringer Ingelheim5$102
Apellis Pharmaceuticals, Inc.5$101
Exelixis Inc.6$100
E.r. Squibb & Sons, L.L.C.1$97
Sobi, Inc6$94
Rigel Pharmaceuticals, Inc.5$91
Genmab U.S., Inc.5$91
Blue Earth Diagnostics4$85
Clovis Oncology, Inc.6$81
Pharmacosmos Therapeutics Inc.4$76
Karyopharm Therapeutics Inc.4$67
Pfizer4$66
Array Biopharma Inc4$66
Servier Pharmaceuticals LLC4$64
Acrotech Biopharma Inc.3$57
AMAG Pharmaceuticals, Inc.4$53
Kyowa Kirin, Inc.3$46
Coherus Oncology, Inc.3$44
Adaptive Biotechnologies Corporation2$44
Jazz Pharmaceuticals Inc.2$42
Legend Biotech USA Inc.2$41
EMD Serono, Inc.3$39
Spectrum Pharmaceuticals Inc.2$35

How this compares

$15,017 in reported general payments places this provider in the 90th percentile of 54 radiation oncology providers in Kansas.

See all radiation oncology providers in Kansas

Medicare billing

Part B allowed, 2024
$588,227
Medicare patients
427
Services billed
5,921

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →